Article

Cancer patients facing delays in receiving paclitaxel

The FDA released information today regarding manufacturing delays and an increase in demand for paclitaxel injection, a generic drug used for many different types of cancers. (You can read the full brief at FDA Drug Shortages.)This marks only the latest cancer drug shortage. Problems with paclitaxel availability were first announced in May (more information can be found in Drug Shortages Leave Cancer Patients at Risk via Medpage Today).The New York Times published an excellent opinion piece this past weekend by Ezekiel J. Emanuel (Shortchanging Cancer Patients) that explained how and why so many of these drug shortages are happening -- all of which are generic and inexpensive drugs. We'll be reporting more on this topic in an upcoming CURE issue, so stay tuned. In the meantime, let us know if and how you've been affected by the recent drug shortages.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of Doctor.
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Image of Dr. Doug
Image of doctor.
Image of Dr. Kelly
Image of Dr. Boffa.
2 experts are featured in this series.
2 experts are featured in this series.
Immune Therapy Expands Melanoma Treatment to More Patients
Related Content